Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Tranexamic Acid in the Treatment of Lichen Planus Pigmentosus and Erythema Dyschromicum Perstans

NCT04233749 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT04233749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04233749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Tranexamic Acid in the Treatment of Lichen Planus Pigmentosus and Erythema Dyschromicum Perstans
Lead sponsor
Henry Ford Health System
Phase
Phase 2
Overall status
Recruiting
Start date
March 17, 2020
Completion date
December 30, 2025
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ashy dermatosis of ramirez, erythema dyschromicum perstans, lichen planus pigmentosus